<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2307-3349</journal-id>
<journal-title><![CDATA[Revista de salud publica del Paraguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. salud publica Parag.]]></abbrev-journal-title>
<issn>2307-3349</issn>
<publisher>
<publisher-name><![CDATA[INSTITUTO NACIONAL DE SALUD - MSP Y BS]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2307-33492017000100045</article-id>
<article-id pub-id-type="doi">10.18004/rspp.2017.junio.45-49</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Mesotelioma Pleural. Reporte de caso. Hospital de Clínicas. Asunción, Paraguay]]></article-title>
<article-title xml:lang="en"><![CDATA[Pleural MesotheliomaCase report. Hospital of Clinics. Asunción, Paraguay]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Narváez]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amarilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flores]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Asunción Facultad de Ciencias Médicas Tercera Cátedra de Clínica Médica]]></institution>
<addr-line><![CDATA[San Lorenzo ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Dirección General de Salud Ambiental Investigación para el Desarrollo]]></institution>
<addr-line><![CDATA[Asunción ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<volume>7</volume>
<numero>1</numero>
<fpage>45</fpage>
<lpage>49</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2307-33492017000100045&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2307-33492017000100045&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2307-33492017000100045&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Paciente varón de 49 años, No conocido portador de patología de base, ingresó por sensación febril con escalofríos, cefalea, mialgias. Tres días antes del ingreso, tos con expectoración blanquecina, dolor en punta de costado del lado izquierdo y dificultad respiratoria. Examen Físico: PA: 107/61 FC: 96 X' FR: 24 X' Tax: 36°C. Aparato Respiratorio: Murmullo vesicular conservado del lado derecho. Abolido en campo medio y base del lado izquierdo. Sistema Hemolinfopoyético: Adenomegalias múltilples en región inguinal bilateral, móviles, pequeñas, no dolorosas. Evolución: Se instaló tubo de drenaje pleural, por importante derrame pleural. Se realizó toracoscopía, se constató masa extrabronquial y se tomó biopsia. La anatomía patológica + Inmunohistoquímica informa, tumor de alto grado más compatible con Mesotelioma. El paciente falleció al mes del diagnóstico. El mesotelioma pleural se considera una patología laboral-ambiental, causada por la inhalación de fibras de asbesto o amianto, tiene un mal pronóstico y es una enfermedad prevenible. Existen serias discusiones sobre prohibición del uso del asbesto. En algunos países está prohibida su importación/exportación, no así en Paraguay.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Male, 49 years old, without any disease, entered by feeling feverish, with chills, headache, myalgia. Three days before hospital admission, he presents with cough and whitish sputum and pain in left side tip and respiratory distress. At physical examination: BP: 107/61; HR: 96 X' ; RR: 24 X'; T: 36°C. Respiratory: Breath sounds on the right side preserved, abolished in base and midfield on left side. Haemolynphopoietic system: lynphadenopathy inguinal region, mobile, small, painless. Evolution: He settled chest tube, because of an important pleural effusion. Thoracoscopy was performed, an extrabronchial mass was found and a biopsy was taken. Pathology + Inmunohistochemistry says, high grade tumor that seems a pleural mesothelioma. The patient died a month after his diagnosis. Pleural Mesothelioma considered as a pathology labor - enviromental, caused by the inhalation of asbestos fibers. There are serious discussions about banning the use of asbestos. In some countries import / export is prohibited, but not in Paraguay.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Mesotelioma pleural]]></kwd>
<kwd lng="es"><![CDATA[Asbesto]]></kwd>
<kwd lng="es"><![CDATA[Paraguay]]></kwd>
<kwd lng="en"><![CDATA[Pleural mesothelioma]]></kwd>
<kwd lng="en"><![CDATA[Asbesto, Paraguay]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>American Thoracic Society</collab>
<article-title xml:lang=""><![CDATA[Diagnosis and initial management of nonmalignant diseases related to asbestos]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2004</year>
<page-range>170-691</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jett]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<source><![CDATA[Mesotelioma maligno.En: Albert R, Spiro S, Jett J, editores. Tratado de neumología]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Harcourt]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin Chu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Malignant mesothelioma ininfancy]]></article-title>
<collab>Lee Y-J Ho MY</collab>
<source><![CDATA[Arch Pathol Lab Meth]]></source>
<year>1989</year>
<volume>113</volume>
<page-range>409</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farreras]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Medicina interna]]></source>
<year>2004</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escobar Agudelo]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Cuesta Herrera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Correa]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez Ramírez]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Maya Montoya]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos Zapata]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Vásquez]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asbestosis epidemiología, prevención y tratamiento]]></article-title>
<source><![CDATA[Revista CES Salud Pública]]></source>
<year>2012</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>251-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Testa]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Pass]]></surname>
<given-names><![CDATA[HI]]></given-names>
</name>
<name>
<surname><![CDATA[Carbone]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Benign and malignant mesothelioma.En: Principles and practice of oncology]]></source>
<year>2001</year>
<edition>6</edition>
<publisher-loc><![CDATA[PA ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams &amp; Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Müller]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Colman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Enfermedad pleural.En: Müller F, Colman P, editores. Diagnóstico radiológico de las enfermedades del tórax]]></source>
<year>2000</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier Science]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sterman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kaiser]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Albelda]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Alavi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic imaging of malignant pleural mesothelioma with uorodeoxyglucose positron emission tomographic]]></article-title>
<source><![CDATA[Chest]]></source>
<year>1998</year>
<page-range>114-713</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pistolesi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rusthoven]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Malignant pleural mesothelioma, update current management, and newer therapeutic strategies]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2004</year>
<volume>126</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1318-29</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nicholas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vogelzang]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multimodality therapy in mesothelioma role of chemotherapy]]></article-title>
<source><![CDATA[Thorac Surg Clin]]></source>
<year>2004</year>
<numero>14</numero>
<issue>14</issue>
<page-range>531-42</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[Sugarbaker]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Innovative therapies intraoperative intracavitary chemotherapy]]></article-title>
<source><![CDATA[Thorac Surg Clin]]></source>
<year>2004</year>
<numero>14</numero>
<issue>14</issue>
<page-range>549-56</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Villena]]></surname>
<given-names><![CDATA[MV]]></given-names>
</name>
</person-group>
<source><![CDATA[Mesotelioma pleural.En: Pérez E, Villena MV, editores. Enfermedades de la pleura]]></source>
<year>2003</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ergon]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sterman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Treat]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Litzky]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Coonrod]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Molnar Kimber]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovirgene therapy in patients with localized malignancy results of a phase I clinical trial in malignant mesothelioma]]></article-title>
<source><![CDATA[Hum Gene Ther]]></source>
<year>1998</year>
<volume>9</volume>
<page-range>1083</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
<name>
<surname><![CDATA[Rom]]></surname>
<given-names><![CDATA[WN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in mortality of diffuse malignant mesothelioma of pleura]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1983</year>
<volume>2</volume>
<page-range>112-3</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Surviving the asbestos epidemic.En: Insurance digest (European)]]></source>
<year>2001</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Pricewater House Coopers]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carroll]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hensler]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Abrahamse]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gross]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ashwood]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Asbestos litigation costs and compensation: an interim report]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Santa Mónica ]]></publisher-loc>
<publisher-name><![CDATA[RAND Institute for Civil Justice]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peto]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Decarli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[La Vecchia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Levi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Negri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The european mesothelioma epidemic]]></article-title>
<source><![CDATA[Br J Cancer]]></source>
<year>1999</year>
<volume>79</volume>
<page-range>666-72</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murayama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemic of asbestos related diseases]]></article-title>
<source><![CDATA[Proceedings of the Global Asbestos Congress, November 19-21]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Tokyo ]]></publisher-loc>
<publisher-name><![CDATA[World Asbestos Report]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Emerging health effects of asbestos in Asia.En: Proceedings of the Global Asbestos Congress, November 19-21]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Tokyo ]]></publisher-loc>
<publisher-name><![CDATA[World Asbestos Report]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<source><![CDATA[Banco Central del Paraguay]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<source><![CDATA[Informe sobre importaciones de Paraguay]]></source>
<year>2016</year>
<publisher-name><![CDATA[COMEX]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
